CrisprBits Raises $3 Million to Expand CRISPR Biotech Platforms
Big win for Indian biotech. CrisprBits raises $3M to accelerate CRISPR diagnostics, gene editing and global product rollout.
Big win for Indian biotech. CrisprBits raises $3M to accelerate CRISPR diagnostics, gene editing and global product rollout.
PharmEasy raises ₹1,700 Cr via NCDs to repay Goldman Sachs loan. Losses are down, Thyrocare profits up, IPO talks back. Bold strategy or risky gamble?